Search Results - "Nappi, R. E."

Refine Results
  1. 1

    Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause by Nappi, R. E., Palacios, S.

    “…ABSTRACT Vulvovaginal atrophy (VVA) or atrophic vaginitis is a medical challenge because it is under-reported by women, under-recognized by health-care…”
    Get full text
    Journal Article
  2. 2

    Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey by Nappi, R. E., Kokot-Kierepa, M.

    “…Objective To assess knowledge of vaginal atrophy among women using the Vaginal Health: Insights, Views & Attitudes (VIVA) survey. Methods A structured online…”
    Get full text
    Journal Article
  3. 3

    Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: A randomised, placebo-controlled, phase III trial by Portman, D, Palacios, S, Nappi, R.E, Mueck, A.O

    Published in Maturitas (01-06-2014)
    “…Abstract Objective To evaluate the efficacy and safety of ospemifene, a novel selective oestrogen receptor modulator, in the treatment of vaginal dryness in…”
    Get full text
    Journal Article
  4. 4

    Course of migraine during pregnancy and postpartum: a prospective study by Sances, G, Granella, F, Nappi, R E, Fignon, A, Ghiotto, N, Polatti, F, Nappi, G

    Published in Cephalalgia (01-04-2003)
    “…The aim of this study was to investigate prospectively the course of migraine during pregnancy and postpartum. Of all the pregnant women consecutively…”
    Get more information
    Journal Article
  5. 5

    Differences in sexual desire between women with clinical versus biochemical signs of hyperandrogenism in polycystic ovarian syndrome by Rellini, A.H., Stratton, N., Tonani, S., Santamaria, V., Brambilla, E., Nappi, R.E.

    Published in Hormones and behavior (01-01-2013)
    “…The role androgens play in female sexual desire remains unclear. We investigated whether androgen sensitivity or elevated androgen levels contributed to sexual…”
    Get full text
    Journal Article
  6. 6

    Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study by Facchinetti, F, Allais, G, Nappi, R E, D'Amico, R, Marozio, L, Bertozzi, L, Ornati, A, Benedetto, C

    Published in Cephalalgia (01-03-2009)
    “…The aim was to assess whether women suffering from migraine are at higher risk of developing hypertensive disorders in pregnancy. In a prospective cohort…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Premature ovarian insufficiency: an International Menopause Society White Paper by Panay, N., Anderson, R. A., Nappi, R. E., Vincent, A. J., Vujovic, S., Webber, L., Wolfman, W.

    “…The aim of this International Menopause Society White Paper on premature ovarian insufficiency (POI) is to provide the latest information regarding this…”
    Get full text
    Journal Article
  9. 9

    Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation by Corrao, G., Zambon, A., Conti, V., Nicotra, F., La Vecchia, C., Fornari, C., Cesana, G., Contiero, P., Tagliabue, G., Nappi, R. E., Merlino, L.

    Published in Annals of oncology (01-01-2008)
    “…Background: The effects of persistence with hormone replacement therapy (HRT) on the risk of hospitalization for cancer and of the route of HRT administration…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause by Palacios, S, Nappi, R E, Bruyniks, N, Particco, M, Panay, N

    “…The primary objective of the European Vulvovaginal Epidemiological Survey (EVES) was to assess, at a country level, the prevalence of postmenopausal women with…”
    Get full text
    Journal Article
  12. 12

    Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres by Granella, F, Sances, G, Allais, G, Nappi, R E, Tirelli, A, Benedetto, C, Brundu, B, Facchinetti, F, Nappi, G

    Published in Cephalalgia (01-09-2004)
    “…Aim of this study was to determine whether menstrual attacks differ from nonmenstrual attacks (NMA) as regards clinical features or response to abortive…”
    Get more information
    Journal Article
  13. 13

    Diaries and calendars for migraine. A review by Nappi, G, Jensen, R, Nappi, R E, Sances, G, Torelli, P, Olesen, J

    Published in Cephalalgia (01-08-2006)
    “…Headache is one of the most common types of pain and, in the absence of biological markers, headache diagnosis depends only on information obtained from…”
    Get more information
    Journal Article
  14. 14

    Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey by Nappi, R. E., Palacios, S., Panay, N., Particco, M., Krychman, M. L.

    “…Objectives The aim of the European REVIVE survey was to achieve a better understanding of vulvovaginal atrophy (VVA), a chronic and progressive condition after…”
    Get full text
    Journal Article
  15. 15

    Circulating Levels of Allopregnanolone in Humans: Gender, Age, and Endocrine Influences by Genazzani, A. R, Petraglia, F, Bernardi, F, Casarosa, E, Salvestroni, C, Tonetti, A, Nappi, R. E, Luisi, S, Palumbo, M, Purdy, R. H, Luisi, M

    “…Allopregnanolone is a neuroactive steroid involved in modulating behavioral functions, stress, and neuroendocrine axes in rats. Changes in plasma…”
    Get full text
    Journal Article
  16. 16

    Understanding weight gain at menopause by Davis, S. R., Castelo-Branco, C., Chedraui, P., Lumsden, M. A., Nappi, R. E., Shah, D., Villaseca, P.

    “…ABSTRACT Objective The aim of this review was to summarize the literature regarding the impact of the menopause transition on body weight and body composition…”
    Get full text
    Journal Article
  17. 17

    Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? by Biglia, N., Cagnacci, A., Gambacciani, M., Lello, S., Maffei, S., Nappi, R. E.

    “…Menopausal disorders may include shorter-term symptoms, such as hot flushes and night sweats (vasomotor symptoms, VMS) and longer-term chronic conditions such…”
    Get full text
    Journal Article
  18. 18

    To be or not to be in sexual desire: the androgen dilemma by Nappi, R. E.

    “…The androgen milieu and sexual desire in women seem to be tightly linked because they both decline with age. However, we are still missing a cut-off plasma…”
    Get full text
    Journal Article
  19. 19

    A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study by Salvatore, S., Nappi, R. E., Zerbinati, N., Calligaro, A., Ferrero, S., Origoni, M., Candiani, M., Leone Roberti Maggiore, U.

    “…Abstract Objective This pilot study aimed to assess the efficacy and feasibility of fractional CO2 laser in the treatment of vulvovaginal atrophy (VVA) in…”
    Get full text
    Journal Article
  20. 20

    Insomnia and menopause: a narrative review on mechanisms and treatments by Proserpio, P., Marra, S., Campana, C., Agostoni, E. C., Palagini, L., Nobili, L., Nappi, R. E.

    “…The menopausal transition is associated with an increased frequency of sleep disturbances. Insomnia represents one of the most reported symptoms by menopausal…”
    Get full text
    Journal Article